Your browser doesn't support javascript.
loading
Melanoma and eruptive naevi during cetuximab treatment: epidermal growth factor inhibitors and a common concern.
Ferrari, T; Lambertini, M; Tartari, F; Dika, E.
Affiliation
  • Ferrari T; Division of Dermatology, IRCCS di Policlinico Sant'Orsola, Bologna, Italy.
  • Lambertini M; Division of Dermatology, IRCCS di Policlinico Sant'Orsola, Bologna, Italy.
  • Tartari F; Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Dika E; Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Clin Exp Dermatol ; 46(8): 1584-1586, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34080222
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Epidermal Growth Factor / ErbB Receptors / Cetuximab / Nevus, Pigmented Limits: Humans / Male / Middle aged Language: En Journal: Clin Exp Dermatol Year: 2021 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Epidermal Growth Factor / ErbB Receptors / Cetuximab / Nevus, Pigmented Limits: Humans / Male / Middle aged Language: En Journal: Clin Exp Dermatol Year: 2021 Document type: Article Affiliation country: Italy